BrightInsight is a digital health platform that powers digital health transformation for life sciences companies, delivering scalable, compliant, cloud-based solutions to revolutionize patient outcomes.

BrightInsight provides the leading global platform for biopharma and medtech regulated digital health solutions. 

We are the launch partner companies trust to accelerate time to market for regulated digital health products including apps, algorithms, medical devices, connected combination products, companion diagnostics, and Software as a Medical Device (SaMD). 

BrightInsight replaces the need for lengthy and complex ‘build from scratch’ implementations. Instead, we offer a proven platform and configurable software modules, built to meet the most stringent global security, privacy, and regulatory requirements. We can also serve as the Legal Manufacturer of Record for your digital health products. 

When building your digital health solutions on the BrightInsight®️ Platform, you are future-proofing compliance while ensuring scalability across geographies.

New Leaf Venture Partners

Eclipse Ventures

Insight Partners

Gaingels

General Catalyst

Sand Hill Angels

Red Hook Capital

BrightInsight

It’s more than a New Year’s resolution. It’s a whole new BrightInsight. We’re kicking off 2024 with a brand-new look and feel that shines brighter—showcasing our position as the trusted partner and de facto platform for digital health. 🎉🏆🤩

✨ See more at https://brightinsight.com/

This year was one of contraction in the #digitalhealth space, starting with a “new normal” investment climate. Given the current landscape, pharmaceutical and medical device companies are right to be chary of potential digital health partners. 

In this new Forbes article, Kal Patel, M.D., MBA discusses how pharmaceutical and medical device companies can distinguish high-quality companies. Learn more: https://lnkd.in/gaueBD8k

At #JPM2024, we asked entrepreneurs, biopharma executives, and thought leaders on their top 2024 predictions! 🧠🎤 Here's what they told us.

A big thank you to Emmanuel Frenehard (Sanofi), Justin Butler (Eclipse Ventures), Amar Goel (Bito), Kal Patel, M.D., MBA (BrightInsight), Stephen R. (Roche), Donald Jones (Takeda), and Ashish Agrawal (BrightInsight) for sharing your thoughts with us!

Also check out this new #JPM blog from Kal Patel, M.D., MBA: JPM Healthcare Conference: Is Generative AI Ready for Life Sciences? https://lnkd.in/gW57hSeP

Ready to start your digital transformation but worried about how long it will take to have a measurable impact on your clinical and business goals? That’s where we come in. 💡🏆✨

In our new eBook, we’re outlining the many reasons working with a proven technology partner is the best way to accelerate speed to value. Read our eBook to learn more: https://lnkd.in/gKTtBFgt

Kicked off the new year with a bang at #JPM2024 in San Francisco! 💥🎉 Jamie Eisinger Burgess, Kal Patel, M.D., MBA, and Ashish Agrawal rang the closing bell with Nasdaq and the other Deloitte Technology #Fast500 winners! 

The Deloitte Technology Fast 500 list is comprised of the fastest-growing technology, life sciences, media, telecommunications, fintech and energy tech companies - both public and private - in North America. 🚀🌎

We are honored to be ranked 307th on the list and to have joined the other companies on the Nasdaq tower! 🤝

#digitalhealth #brightinsight #nasdaq #jpm23

…ready for it? 🚨

 January 8th, 2024 👀

Something BIG is coming 🤔✨

As this year comes to a close, we want to thank you for being part of the BrightInsight community. Happy Holidays and Happy New Years! - from your friends at BrightInsight 🎄❄️🌟

That’s a wrap on 2023! 🥳 This year, BrightInsight entered our #LaunchEra, helping our customers drive revenue, improve patient outcomes and build brand loyalty through new product launches and global expansion. 🚀🏆🌎

We’re excited for what 2024 holds for BrightInsight, our team members, our customers, and the #digitalhealth industry as a whole. Check out our 2023 Wrapped video to see our top highlights for the year! 🎉

We are excited to announce major milestones for CSL Behring’s Hizentra app, which supports patients taking #Hizentra with medication reminders, record management, infusion tracking and more! 📣

The latest version of the app introduces exciting new capabilities and an updated design. The update also expands the app’s footprint geographically, reaching new markets in Latin America and Canada, in addition to the existing regions of the U.S. and Japan. 🌎 Learn more in our new blog: https://bit.ly/3RnWfEc

In recent conversations, a common theme has emerged: Frontline marketing teams are limited in their thinking around digital health strategy. But in the C-suite, the thinking is that digital is an ideal way to cut through the noise and deliver much more impact on the patient experience and the bottom line.

In this new Forbes article, Kal Patel, M.D., MBA shares some steps on how pharma marketing teams can think bigger about digital: https://lnkd.in/gFHGDeH6

COM:BRIGHTINSIGHT

BrightInsight

Analysis Not Available